Nine Month Performance
Consolidated sales for the period was higher by 2% to Rs 2313.40 crore. But with 290 bps contraction in OPM to 16.1% the operating profit was down by 14% to Rs 373.34 crore. The PBT was down by 17% to Rs 360.60 crore after accounting for lower OI, higher interest and higher depreciation. With taxation stand lower by 35% to Rs 98.54 crore, the PAT was down by 7% to Rs 262.06 crore.
The segment revenue of S&I was down by 1% to Rs 877.90 crore and that together with 460 bps contraction in segment margin resulted in 23% fall in segment profit to Rs 142.61 crore. However the T&E business despite 3% growth in sales to Rs 782.58 crore has seen its segment profit down by 24% to Rs 65.53 crore as its segment margin down by 310 bps to 8.4%. The segment profit of healthcare was down by 19% to Rs 62.04 crore hit largely by 440 bps to 16.2% as its segment sales was up by modest 3% to Rs 382.16 crore. But the segment profit of consumer was up by 22% to Rs 55.50 crore facilitated by higher sales (up 7% to RS 251.53 crore) and 270 bps expansion in segment margin to 22.1%. The segment profit of others was down by 35% to Rs 4.22 crore.